Kahn M J, Kieber-Emmons T, Vilaire G, Murali R, Poncz M, Bennett J S
Hematology-Oncology Division, Hospital of the University of Pennsylvania, Philadelphia, USA.
Biochemistry. 1996 Nov 12;35(45):14304-11. doi: 10.1021/bi961702x.
A G273D mutation immediately proximal to the first calcium binding domain of platelet GPIIb impairs the export of GPIIb-IIIa heterodimers to the platelet surface. To examine how this mutation might alter the structure of GPIIb, G273 was replaced by other amino acids and the resulting mutants were coexpressed with GPIIIa in COS-1 cells. Although replacement with Ala or Val had no effect on GPIIb-IIIa expression, replacement with Glu, Lys, Pro, or Asn caused intracellular retention of GPIIb-IIIa. Concurrently, the consequences of these replacements were examined by comparative modeling by introducing them into the analogous position of the first helix-loop-helix (HLH) motif of calmodulin, based on homology between the calcium binding domains of GPIIb and the calcium binding loops of HLH-containing proteins. The modeling revealed that as the side chain of the introduced amino acid increased in size, it progressively interfered with hydrophobic interactions between the incoming and outgoing helices of the motif. To test whether this observation also applies to GPIIb, V286, located immediately distal to the first GPIIb calcium binding domain, was replaced by Asp and Phe. Expression of these mutants in COS-1 cells also resulted in the intracellular retention of GPIIb-IIIa, suggesting that interactions between sequences that flank the first calcium binding domain of GPIIb affect its folding. Finally, the endoplasmic reticulum chaperone BiP was detected in immunoprecipitates of GPIIb-IIIa containing GPIIb with Ala, Val, Lys, or Pro, but not Gly, at position 273. This suggests that although BiP binding is a sensitive indication of the fidelity of GPIIb-IIIa folding, it is not sufficient to account for the intracellular retention of the heterodimer.
血小板糖蛋白IIb(GPIIb)第一个钙结合结构域紧邻处的G273D突变会损害GPIIb-IIIa异二聚体向血小板表面的转运。为了研究该突变如何改变GPIIb的结构,将G273替换为其他氨基酸,并使所得突变体与GPIIIa在COS-1细胞中共表达。虽然用丙氨酸(Ala)或缬氨酸(Val)替换对GPIIb-IIIa表达没有影响,但用谷氨酸(Glu)、赖氨酸(Lys)、脯氨酸(Pro)或天冬酰胺(Asn)替换会导致GPIIb-IIIa在细胞内滞留。同时,基于GPIIb的钙结合结构域与含螺旋-环-螺旋(HLH)蛋白的钙结合环之间的同源性,通过比较建模将这些替换引入钙调蛋白第一个HLH基序的类似位置,研究这些替换的后果。建模显示,随着引入氨基酸侧链大小的增加,它逐渐干扰该基序中进出螺旋之间的疏水相互作用。为了测试这一观察结果是否也适用于GPIIb,将紧邻第一个GPIIb钙结合结构域的V286分别替换为天冬氨酸(Asp)和苯丙氨酸(Phe)。这些突变体在COS-1细胞中的表达也导致GPIIb-IIIa在细胞内滞留,表明GPIIb第一个钙结合结构域两侧序列之间的相互作用影响其折叠。最后,在内质网伴侣BiP的免疫沉淀中检测到,在273位含有Ala、Val、Lys或Pro而非Gly的GPIIb的GPIIb-IIIa中存在BiP。这表明,虽然BiP结合是GPIIb-IIIa折叠保真度的敏感指标,但它不足以解释异二聚体在细胞内的滞留。